-
Mashup Score: 3ASTCT Learning Center: Pharmacy HCT Core Topics Spring 2024 Live Session - Immunosuppression Management and HCT Complications - 9 hour(s) ago
The Pharmacy HCT Core Topics Live Session will air on Wednesday, May 8, at 2 pm CT/3 pm ET. This live session will focus on two core topics in hematopoietic cell transplantation and cellular therapy- Immunosuppression management and HCT complications. The faculty below will answer questions about their respective topics and share their experiences from their institutions. The target audience is PGY2 Oncology Pharmacy Residents, but is open to all trainees practicing or interested in transplantation and
Source: learn.astct.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2Tissue-infiltrating alloreactive T cells require Id3 to deflect PD-1–mediated immune suppression during GVHD - 1 day(s) ago
Researchers have discovered a significant function of the Id3 protein in the persistence and operational capabilities of tissue-infiltrating alloreactive T cells, offering insights that could…
Source: www.astct.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 9ASTCT Talks: Beyond Remission: Navigating the Late Effects of Pediatric CAR T-Cell Therapy - 2 day(s) ago
In this episode “ASTCT Talks,” hosts Rebecca Epperly, MD, and Aimee Talleur, MD, from St. Jude Children’s Research Hospital, dive into the pioneering realm of CAR T-cell therapy and…
Source: www.astct.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 5ASTCT Learning Center: Home - 5 day(s) ago
The first in ASTCT’s new CAR T Webinar Series aired on June 9, 2021 with our speaker, Dr. Marcela Maus, and our moderator, Dr. Armin Ghobadi. This webinar,’ CAR T Basics and Biology’ covered an overall review of CAR T Biology, the general process of generating CAR T, CAR T targets, the future directions of CAR T biology, and more! Register Non-member – Free! Member – Free! To view personalized recommendations of education content login to your member profile. Contains 3 Component(s) The first in ASTCT’s
Source: learn.astct.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3ASTCT Learning Center: Pharmacy HCT Core Topics Spring 2024 Live Session - Immunosuppression Management and HCT Complications - 6 day(s) ago
The Pharmacy HCT Core Topics Live Session will air on Wednesday, May 8, at 2 pm CT/3 pm ET. This live session will focus on two core topics in hematopoietic cell transplantation and cellular therapy- Immunosuppression management and HCT complications. The faculty below will answer questions about their respective topics and share their experiences from their institutions. The target audience is PGY2 Oncology Pharmacy Residents, but is open to all trainees practicing or interested in transplantation and
Source: learn.astct.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2
Introduction: Advanced Practice Providers (APPs) play a crucial role in the functioning of transplant and cellular therapy programs of all sizes. Physician Assistant and Nurse Practitioner academic programs provide little training specific to HSCT and cellular therapy. However, this area of health care requires specialized knowledge and skills. Transplant and cellular therapy programs in medical institutions must develop their own educational plans and resources. These can range from very minimal to
Source: learn.astct.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 20
The number of long-term survivors of hematopoietic cell transplantation (HCT) and cellular therapy is rapidly expanding. Guidelines for the screening and preventative practices for HCT survivors was last published in 2012. This webinar will review the 2023 updated guidelines for pediatric and adult survivorship for HCT and cellular therapy. We will highlight changes to the guidelines from 2012, reflecting contemporary practice and data, emphasizing special needs of patients with distinct HCT indications
Source: learn.astct.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2Early inflammatory markers as prognostic indicators following allogeneic stem cell transplantation - 10 day(s) ago
Researchers at the University of Birmingham in the UK have explored the dynamics of inflammatory biomarkers following allogeneic hematopoietic stem cell transplantation. This study seeks to…
Source: www.astct.orgCategories: General Medicine News, Onc News and JournalsTweet-
Researchers at the University of Birmingham have explored dynamics of inflammatory biomarkers following #alloSCT. This study seeks to enhance early prediction of patient outcomes by monitoring of 92 proteins after transplantation. Read more on Nucleus: https://t.co/wA25HE8p2a https://t.co/vWUvKR1FoJ
-
-
Mashup Score: 9
Program Description: Articles designated for CME credit are designed to be the next step in the process of translating clinically relevant, evidence-based recommendations into clinical practice. This will be accomplished through a series of questions specifically designed to test that readers have the tools needed to translate recommendations for diagnostic and therapeutic clinical care into clinical practice. Post-test questions will assess if practitioners have understood the most important recommendation
Source: learn.astct.orgCategories: General Medicine News, Onc News and JournalsTweet-
NEW CME Opportunity ✨ Read the latest ASTCT Practice Guidelines, take a comprehension quiz & earn CME! 3 articles will be available, the first of which is online now. This free continuing education activity should take around 1 hr & is eligible for 1 CME. https://t.co/2o87W3wuEN https://t.co/K7KVraJGmZ
-
-
Mashup Score: 20
The number of long-term survivors of hematopoietic cell transplantation (HCT) and cellular therapy is rapidly expanding. Guidelines for the screening and preventative practices for HCT survivors was last published in 2012. This webinar will review the 2023 updated guidelines for pediatric and adult survivorship for HCT and cellular therapy. We will highlight changes to the guidelines from 2012, reflecting contemporary practice and data, emphasizing special needs of patients with distinct HCT indications
Source: learn.astct.orgCategories: General Medicine News, Onc News and JournalsTweet
Join us on May 8 for the Pharmacy #HCT Core Topics live session on immunosuppression management and HCT complications. Register for free: https://t.co/MHZoifTuvg https://t.co/f7SgvYIqoo